JPH04334308A - Skin cosmetic - Google Patents
Skin cosmeticInfo
- Publication number
- JPH04334308A JPH04334308A JP3135452A JP13545291A JPH04334308A JP H04334308 A JPH04334308 A JP H04334308A JP 3135452 A JP3135452 A JP 3135452A JP 13545291 A JP13545291 A JP 13545291A JP H04334308 A JPH04334308 A JP H04334308A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- extract
- vitamin
- cosmetic
- effect
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Natural products CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 43
- 239000000284 extract Substances 0.000 claims abstract description 23
- 235000019441 ethanol Nutrition 0.000 claims abstract description 17
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims abstract description 10
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims abstract description 9
- 240000004371 Panax ginseng Species 0.000 claims abstract description 8
- 235000002789 Panax ginseng Nutrition 0.000 claims abstract description 8
- 230000017531 blood circulation Effects 0.000 claims abstract description 8
- 235000008434 ginseng Nutrition 0.000 claims abstract description 8
- -1 D-pantothenyl ethyl Chemical group 0.000 claims abstract description 6
- ILKBHIBYKSHTKQ-UHFFFAOYSA-N Diisopropylamine dichloroacetate Chemical compound OC(=O)C(Cl)Cl.CC(C)NC(C)C ILKBHIBYKSHTKQ-UHFFFAOYSA-N 0.000 claims abstract description 5
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 claims abstract description 5
- 229960002685 biotin Drugs 0.000 claims abstract description 5
- 235000020958 biotin Nutrition 0.000 claims abstract description 5
- 239000011616 biotin Substances 0.000 claims abstract description 5
- 229940084113 diisopropylamine dichloroacetate Drugs 0.000 claims abstract description 5
- VMKSKORGKQPVAO-SECBINFHSA-N ethyl 3-[[(2S)-2,4-dihydroxy-3,3-dimethylbutanoyl]amino]propanoate Chemical compound CCOC(=O)CCNC(=O)[C@@H](O)C(C)(C)CO VMKSKORGKQPVAO-SECBINFHSA-N 0.000 claims abstract description 5
- 229950009883 tocopheryl nicotinate Drugs 0.000 claims abstract description 5
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229960004756 ethanol Drugs 0.000 claims abstract description 4
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims abstract description 4
- 230000001737 promoting effect Effects 0.000 claims abstract description 4
- 244000184734 Pyrus japonica Species 0.000 claims description 9
- 239000004615 ingredient Substances 0.000 claims description 4
- 235000010254 Jasminum officinale Nutrition 0.000 claims description 3
- 240000005385 Jasminum sambac Species 0.000 claims description 3
- 230000003213 activating effect Effects 0.000 claims description 3
- OTAFHZMPRISVEM-UHFFFAOYSA-N chromone Chemical compound C1=CC=C2C(=O)C=COC2=C1 OTAFHZMPRISVEM-UHFFFAOYSA-N 0.000 claims 2
- 239000011782 vitamin Substances 0.000 claims 1
- 229940088594 vitamin Drugs 0.000 claims 1
- 229930003231 vitamin Natural products 0.000 claims 1
- 235000013343 vitamin Nutrition 0.000 claims 1
- 150000003722 vitamin derivatives Chemical class 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 27
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 abstract description 8
- 229930003427 Vitamin E Natural products 0.000 abstract description 4
- 230000032683 aging Effects 0.000 abstract description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 abstract description 4
- PXQPEWDEAKTCGB-UHFFFAOYSA-N orotic acid Chemical compound OC(=O)C1=CC(=O)NC(=O)N1 PXQPEWDEAKTCGB-UHFFFAOYSA-N 0.000 abstract description 4
- 235000019165 vitamin E Nutrition 0.000 abstract description 4
- 229940046009 vitamin E Drugs 0.000 abstract description 4
- 239000011709 vitamin E Substances 0.000 abstract description 4
- 230000001976 improved effect Effects 0.000 abstract description 2
- 241000967294 Swertia japonica Species 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 38
- 238000012360 testing method Methods 0.000 description 17
- 102000011782 Keratins Human genes 0.000 description 7
- 108010076876 Keratins Proteins 0.000 description 7
- 238000011156 evaluation Methods 0.000 description 6
- 230000003712 anti-aging effect Effects 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 210000000434 stratum corneum Anatomy 0.000 description 5
- 206010013786 Dry skin Diseases 0.000 description 4
- 239000012190 activator Substances 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000010998 test method Methods 0.000 description 4
- 230000007306 turnover Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- XPDXVDYUQZHFPV-UHFFFAOYSA-N Dansyl Chloride Chemical compound C1=CC=C2C(N(C)C)=CC=CC2=C1S(Cl)(=O)=O XPDXVDYUQZHFPV-UHFFFAOYSA-N 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 210000000736 corneocyte Anatomy 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 239000002884 skin cream Substances 0.000 description 3
- 241000228212 Aspergillus Species 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 230000036620 skin dryness Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 1
- 240000001857 Phyllostachys elegans Species 0.000 description 1
- 244000046146 Pueraria lobata Species 0.000 description 1
- 235000010575 Pueraria lobata Nutrition 0.000 description 1
- 229940124277 aminobutyric acid Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 229940008396 carrot extract Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000004299 exfoliation Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 239000003871 white petrolatum Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【0001】0001
【産業上の利用分野】本発明は、優れた肌荒れ防止効果
,角質改善効果,老化防止効果及び美肌効果を発現し得
る皮膚化粧料に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to skin cosmetics that can exhibit excellent effects on preventing rough skin, improving keratin, preventing aging, and beautifying the skin.
【0002】0002
【従来の技術及び発明が解決しようとする課題】従来、
肌荒れ防止,肌荒れ改善効果を目的とした皮膚化粧料に
は、生薬抽出エキス,ビタミンEオロテート,ビタミン
Eニコチネート,D−パントテニルエチルエーテル,D
−パントテニルエチルアルコール,ジイソプロピルアミ
ンジクロロアセテート,γ−アミノ酪酸及びビオチン等
の血行促進剤,細胞賦活剤が配合されてきたが、肌荒れ
防止,角質改善及び美肌の各効果は必ずしも十分でなく
、より優れた皮膚化粧料の開発が待望されていた。[Prior art and problems to be solved by the invention] Conventionally,
Skin cosmetics aimed at preventing and improving rough skin include crude drug extracts, vitamin E orotate, vitamin E nicotinate, D-pantothenyl ethyl ether, D
- Blood circulation promoters and cell activators such as pantothenyl ethyl alcohol, diisopropylamine dichloroacetate, γ-aminobutyric acid, and biotin have been formulated, but the effects of preventing rough skin, improving keratin, and beautifying the skin are not necessarily sufficient, and the effects are not necessarily sufficient. The development of superior skin cosmetics has been long awaited.
【0003】本発明者らは、このような皮膚化粧料を開
発すべく鋭意検討した結果、センブリエキス,朝鮮ニン
ジンエキス,ビタミンEオロテート,ビタミンEニコチ
ネート,D−パントテニルエチルエーテル,D−パント
テニルエチルアルコール,ジイソプロピルアミンジクロ
ロアセテート,γ−アミノ酪酸及びビオチンから選ばれ
る1種又は2種以上の血行促進剤,細胞賦活剤及び8−
β−グルコピラノシル−7−ヒドロキシ−3−(3′,
4′−ジヒドロキシフェニル)−4H−1−ベンゾピラ
ン−4−オン(以下、PG1と略記する)を含有する皮
膚化粧料は、優れた肌荒れ防止効果,角質改善効果,美
肌効果を発現するのみならず老化防止効果が著しく高め
られていることを見出し、本発明を完成するに至った。[0003] As a result of intensive studies aimed at developing such skin cosmetics, the present inventors found that the following compounds were found: Jasperum japonica extract, Korean ginseng extract, vitamin E orotate, vitamin E nicotinate, D-pantothenyl ethyl ether, D-pantothenyl. One or more blood circulation promoters selected from ethyl alcohol, diisopropylamine dichloroacetate, γ-aminobutyric acid, and biotin, a cell activator, and 8-
β-glucopyranosyl-7-hydroxy-3-(3',
Skin cosmetics containing 4'-dihydroxyphenyl)-4H-1-benzopyran-4-one (hereinafter abbreviated as PG1) not only exhibit excellent skin roughness prevention effects, keratin improvement effects, and skin beautification effects. It was discovered that the anti-aging effect was significantly enhanced, and the present invention was completed.
【0004】本発明の目的は、優れた肌荒れ防止効果,
角質改善効果,美肌効果,さらに老化防止効果を発現し
得る皮膚化粧料を提供することにある。[0004] The purpose of the present invention is to provide excellent skin roughness prevention effect,
The object of the present invention is to provide a skin cosmetic that can have a keratin-improving effect, a skin beautifying effect, and an anti-aging effect.
【0005】[0005]
【課題を解決するための手段】上記目的を達成する本発
明は、血行促進作用又は細胞賦活作用を有する成分とP
G1を含有することを特徴とする皮膚化粧料である。[Means for Solving the Problems] The present invention achieves the above object by combining an ingredient having a blood circulation promoting effect or a cell activating effect, and P.
This is a skin cosmetic characterized by containing G1.
【0006】前記特定の血行促進剤あるいは細胞賦活剤
のうち、天然物の抽出物であるセンブリエキス、朝鮮ニ
ンジンエキスの製造法に関しては特定されるものではな
いが、各々の製造法の概要は下記の通りである。[0006] Among the above-mentioned specific blood circulation promoters or cell activators, the manufacturing method of the natural product extracts such as Jasmine japonica extract and Korean ginseng extract is not specified, but the outline of each manufacturing method is as follows. It is as follows.
【0007】〔センブリエキスの製造法〕センブリ(S
wertia Japonica Makino)
の開花期全草の乾燥粉砕物をエタノールあるいは含水エ
タノール中で温浸し、ろ別して得られた抽出液である。
実施例には、下記の方法で得られた抽出液を利用した。[Production method of Aspergillus japonica extract] Aspergillus japonica (S.
wertia Japonica Makino)
This is an extract obtained by digesting the dried and pulverized whole plant during flowering period in ethanol or hydrous ethanol and filtering it. In the Examples, an extract obtained by the following method was used.
【0008】センブリ細砕物50gを含水エタノール(
エタノール90wt%)250mlに温度40〜50℃
で温浸してろ別した後、再び残渣を同様に温浸すること
を数回くり返し、抽出液1.5lを得た。これを減圧濃
縮した残留物に精製水を100ml加え、1週間熟成し
た後、不溶部をろ別して得た抽出液を減圧濃縮し、次い
でエタノールを加えて抽出液のエタノール含有量が40
wt%になるように調整し、100mlのセンブリエキ
スを得た。[0008] 50g of crushed Oriental japonica was added to water-containing ethanol (
Add 250 ml of ethanol (90 wt%) to a temperature of 40 to 50°C.
After digesting and filtering, the residue was digested in the same manner several times to obtain 1.5 liters of extract. 100 ml of purified water was added to the residue obtained by concentrating this under reduced pressure, and after aging for 1 week, the insoluble portion was filtered off and the obtained extract was concentrated under reduced pressure. Ethanol was then added to reduce the ethanol content of the extract to 40 ml.
The amount was adjusted to % by weight, and 100 ml of Oriental japonica extract was obtained.
【0009】〔朝鮮ニンジンエキスの製造法〕オタネニ
ンジン(Panax ginseng C.A.M
eyer)の5〜6年根乾燥細砕物をエタノール或いは
含水エタノール中に冷浸し、ろ別して得られた抽出液で
ある。実施例には下記の方法で得られた抽出液を利用し
た。[Production method of Korean ginseng extract] Panax ginseng C.A.M.
This is an extract obtained by cold soaking a 5- to 6-year-old dried and pulverized root of P. elegans in ethanol or water-containing ethanol and filtering it. In the Examples, an extract obtained by the following method was used.
【0010】オタネニンジン細砕物50gを含水エタノ
ール(エタノール90wt%)200mlに1週間冷浸
し、ろ別して得られた抽出液のエタノールを留去し、精
製水を加えて抽出液のエタノール含有量が50wt%に
なるように調整し、更にこれを7〜10週間冷所で熟成
した後、ろ別して100mlの朝鮮ニンジンエキスを得
た。[0010] 50 g of crushed Panax ginseng was cold soaked in 200 ml of aqueous ethanol (90 wt% ethanol) for 1 week, and the ethanol obtained by filtering was distilled off, and purified water was added until the ethanol content of the extract was 50 wt%. After further aging this in a cold place for 7 to 10 weeks, it was filtered to obtain 100 ml of Korean carrot extract.
【0011】前記の血行促進剤または細胞賦活剤を本発
明の化粧料に配合する量は、その作用効果あるいは当該
化粧料の剤型等により適宜調整されるものであるが、通
常後記の表1に示す配合量が好適である。なお配合量は
、化粧料組成物の全量重量を基準とした。[0011] The amount of the blood circulation promoter or cell activator to be blended into the cosmetic of the present invention is appropriately adjusted depending on its effect or the dosage form of the cosmetic, but it is usually as specified in Table 1 below. The blending amount shown in is suitable. The blending amount was based on the total weight of the cosmetic composition.
【0012】0012
【表1】[Table 1]
【0013】これらの中から1種又は2種以上が本発明
の皮膚化粧料に配合される。その含有量は、化粧料の処
方成分全量を基準として0.01〜30重量%が好まし
く、更に好ましくは0.1〜10重量%の範囲内である
。0.01重量%未満では効果が得られにくく、30重
量%を超えると、製品の保存安定性に劣る為、好ましく
ない。One or more of these may be blended into the skin cosmetic of the present invention. Its content is preferably 0.01 to 30% by weight, more preferably 0.1 to 10% by weight, based on the total amount of prescription ingredients of the cosmetic. If it is less than 0.01% by weight, it is difficult to obtain an effect, and if it exceeds 30% by weight, the storage stability of the product will be poor, which is not preferable.
【0014】本発明の皮膚化粧料に用いられるPG1は
、公知の配糖体で〔プランタ・メディカ(Plant
medica),250頁,1988年記載〕、葛根
より公知の方法(上記文献に記載)によって得られる配
糖体である。PG1 used in the skin cosmetic of the present invention is a known glycoside [Planta Medica (Planta Medica)
medica), p. 250, 1988] and kudzu root by a known method (described in the above-mentioned document).
【0015】その含有量は、化粧料の処方成分全量を基
準として、0.0001〜2.0重量%が好ましく、更
に好ましくは、0.001〜1.0重量%の範囲内であ
る。The content thereof is preferably 0.0001 to 2.0% by weight, more preferably 0.001 to 1.0% by weight, based on the total amount of prescription ingredients of the cosmetic.
【0016】即ち、この含有量が0.0001重量%未
満では効果が得られにくく、2.0重量%を超えると製
品の保存安定性が劣るため、好ましくない。That is, if the content is less than 0.0001% by weight, it is difficult to obtain an effect, and if it exceeds 2.0% by weight, the storage stability of the product will be poor, which is not preferable.
【0017】本発明の皮膚化粧料には、上記原料の他に
色素,香料,防腐剤,界面活性剤,顔料,抗酸化剤等を
、本発明の目的を達成する範囲内で適宜配合することが
できる。[0017] In addition to the above-mentioned raw materials, the skin cosmetics of the present invention may contain pigments, fragrances, preservatives, surfactants, pigments, antioxidants, etc. as appropriate within the range that achieves the purpose of the present invention. Can be done.
【0018】本発明の皮膚化粧料の剤型としては、クリ
ーム,乳液,化粧水,パック,パウダー等が挙げられる
。そして、この皮膚化粧料は、例えば乳液等の場合、油
相及び水相をそれぞれ加熱溶解したものを乳化分散して
冷却する通常の方法により製造することができる。[0018] The dosage forms of the skin cosmetics of the present invention include creams, milky lotions, lotions, packs, powders, and the like. In the case of a milky lotion, for example, this skin cosmetic can be produced by a conventional method of heating and dissolving an oil phase and an aqueous phase, emulsifying and dispersing the mixture, and cooling the mixture.
【0019】[0019]
【実施例】以下、実施例及び比較例に基づいて本発明を
詳述する。尚、実施例に示す%とは重量%である。また
、実施例に記載の角質層のターンオーバー速度測定方法
(老化防止効果),荒れ肌改善効果の測定試験法,角質
改善効果の測定試験法,官能テスト(美肌効果)は下記
のとおりである。[Examples] The present invention will be described in detail below based on Examples and Comparative Examples. Note that the percentages shown in the examples are percentages by weight. In addition, the methods for measuring the turnover rate of the stratum corneum (antiaging effect), the test method for measuring the rough skin improving effect, the test method for measuring the keratin improving effect, and the sensory test (skin beautifying effect) described in the Examples are as follows.
【0020】(1)角質層のターンオーバー速度測定方
法
蛍光色素のダンシルクロライドを白色ワセリン中に5重
量%配合した軟膏を作り、被験者の前腕部の皮膚に24
時間閉蓋貼布し、角質層にダンシルクロライドを浸透結
合させる。その後同じ部位に1日2回(朝,夕)被験試
料を塗布し、毎日ダンシルクロライドの蛍光を調べ、そ
の蛍光が消滅するまでの日数を皮膚角質層のターンオー
バー速度とした。なお、通常の皮膚角質層のターンオー
バー速度は、14〜16日であるが、老化した皮膚にお
いては18日前後に延び、それに対して老化防止効果が
現れると12日前後にまで短縮される。(1) Method for measuring the turnover rate of the stratum corneum An ointment containing 5% by weight of the fluorescent dye dansyl chloride in white petrolatum was prepared and applied to the skin of the subject's forearm for 24 hours.
Apply the mask with the lid closed for a period of time to allow dansyl chloride to penetrate and bind to the stratum corneum. Thereafter, the test sample was applied to the same area twice a day (morning and evening), the fluorescence of dansyl chloride was checked every day, and the number of days until the fluorescence disappeared was defined as the turnover rate of the skin stratum corneum. Note that the normal turnover rate of the stratum corneum of the skin is 14 to 16 days, but in aged skin it increases to about 18 days, but when anti-aging effects appear, it shortens to about 12 days.
【0021】(2)荒れ肌改善効果の測定試験法下脚に
荒れ肌を有する中高年被験者20名を対象として4週間
連続塗布効果を調べた。被験者の左側下脚試験部位に1
日2回約1gの試料を塗布し、試験開始前及び終了後の
皮膚の状態を下記の判定基準により判定した。右側下脚
は試料を塗布せず対照とした。
皮膚乾燥度の判定基準
− :正常
± :軽微乾燥,落屑なし
+ :乾燥,落屑軽度
++ :乾燥,落屑中等度
+++:乾燥,落屑顕著
試験前後の試験部位と対照部位の判定結果を比較し、皮
膚乾燥度が2段階以上改善された場合(例えば+→−,
++→±)を「有効」,1段階改善された場合を「やや
有効」,変化がなかった場合を「無効」とした。試験結
果は「有効」,「やや有効」となった被験者の人数で示
した。(2) Test method for measuring the effect of improving rough skin The effect of continuous application for 4 weeks was investigated on 20 middle-aged and elderly subjects who had rough skin on their lower legs. 1 on the subject's left lower leg test site.
Approximately 1 g of the sample was applied twice a day, and the condition of the skin before and after the test was evaluated according to the following criteria. No sample was applied to the right lower leg, which served as a control. Judgment criteria for skin dryness -: Normal ±: Slight dryness, no scaling +: Mild dryness, scaling ++: Moderate dryness, scaling +++: Significant dryness, scaling The judgment results of the test site and control site before and after the test were compared, If the skin dryness has improved by two or more levels (e.g. +→-,
++ → ±) was considered “effective,” one level of improvement was considered “slightly effective,” and no change was considered “ineffective.” The test results are shown in terms of the number of subjects who found the test to be "effective" or "slightly effective."
【0022】(3)角質改善効果(角質細胞の抗剥離性
増大)の測定試験法
前述の荒れ肌改善測定試験開始前及び終了後の被験部皮
膚にスコッチテープ(ニチバンメンディングテープ)を
接着し、これを剥離した時テープに付着した角質細胞の
状態を走査型電子顕微鏡によって詳細に調べ、下記の判
定基準によって皮膚角質細胞の抗剥離性を判定した。
角質改善効果(角質細胞の抗剥離性増大)の判定基準評
価点1:スケールを認めず
評価点2:小スケール点在
評価点3:小〜中スケール顕著
評価点4:大スケール顕著
判定は4週間連続塗布後の試験部位の評価点と対照部位
のそれとの差が2点以上の場合を「有効」,1点の場合
を「やや有効」,0点の場合を「無効」とした。試験結
果は「有効」,「やや有効」となった被験者の人数で示
した。(3) Test method for measuring keratin improving effect (increasing the anti-peeling property of keratinocytes) Scotch tape (Nichiban Mending Tape) is adhered to the skin of the test area before and after the start and end of the rough skin improvement measurement test described above. When the tape was peeled off, the state of the corneocytes adhering to the tape was examined in detail using a scanning electron microscope, and the anti-peeling properties of the skin corneocytes were judged according to the following criteria. Judgment criteria for keratin improving effect (increased anti-exfoliation property of corneocytes) Evaluation score 1: No scale observed Evaluation point 2: Small scale scattered evaluation point 3: Small to medium scale noticeable evaluation point 4: Large scale noticeable evaluation is 4 When the difference between the evaluation score of the test site and that of the control site after weekly continuous application was 2 points or more, it was considered "effective," when it was 1 point, "somewhat effective," and when it was 0 points, "ineffective." The test results are shown as the number of subjects who found the test to be "effective" or "slightly effective."
【0023】(4)官能テスト(美肌効果試験)荒れ肌
,小じわ,乾燥肌等を訴える女子被験者(35〜55才
)20人に試料を1日2回(朝,夕)連続3ケ月間塗布
して、1,2,3ケ月後の効果を評価した。試験結果は
、皮膚の湿潤性,平滑性,弾力性の各項目に対して、「
皮膚に潤いが生じた」,「皮膚が滑らかになった」,「
皮膚に張りが生じた」と回答した人数で示した。(4) Sensory test (skin beautification effect test) The sample was applied twice a day (morning and evening) for 3 consecutive months to 20 female subjects (35 to 55 years old) who complained of rough skin, fine wrinkles, dry skin, etc. The effects were evaluated after 1, 2, and 3 months. The test results were ``skin moisture'', smoothness, and elasticity.
``My skin became moisturized'', ``My skin became smoother'', ``My skin became smoother''
The number of people who answered "My skin became taut" was shown.
【0024】■ 実施例1〜10,比較例1〜12セ
ンブリエキス,朝鮮ニンジンエキス,ビタミンEオロテ
ート,ビタミンEニコチネート,D−パントテニルエチ
ルエーテル,D−パントテニルエチルアルコール,ジイ
ソプロピルアミンジクロロアセテート,γ−アミノ酪酸
及びビオチンから選ばれる1種とPG1を表2の組成に
おいて配合し、下記の調製方法に基いてスキンクリーム
を調製した。各々について前記の諸試験を実施し、その
結果を表3及び表4に示した。■ Examples 1 to 10, Comparative Examples 1 to 12 Jasmine japonica extract, Korean ginseng extract, vitamin E orotate, vitamin E nicotinate, D-pantothenyl ethyl ether, D-pantothenyl ethyl alcohol, diisopropylamine dichloroacetate, γ - One selected from aminobutyric acid and biotin and PG1 were blended in the composition shown in Table 2, and a skin cream was prepared based on the following preparation method. The various tests described above were carried out for each, and the results are shown in Tables 3 and 4.
【0025】[0025]
【表2】[Table 2]
【0026】[0026]
【表3】[Table 3]
【0027】[0027]
【表4】[Table 4]
【0028】■ 調製方法
(A)を70℃,(B)を50℃にて均一に溶解し、(
A)を攪拌しながら(B)を(A)に注入して乳化分散
した後、攪拌しながら温度30℃まで冷却して調製する
。■ Preparation method Dissolve (A) uniformly at 70°C and (B) at 50°C, and (
It is prepared by pouring (B) into (A) while stirring A) to emulsify and disperse it, and then cooling it to a temperature of 30° C. while stirring.
【0029】■ 特性
本発明の実施例1〜10のスキンクリームは、諸特性に
おいて顕著な効果が認められた。一方、比較例1〜12
のスキンクリームは、本発明の実施例に比べて諸特性に
おいて劣っていた。■Characteristics The skin creams of Examples 1 to 10 of the present invention were found to have remarkable effects in various properties. On the other hand, Comparative Examples 1 to 12
The skin creams were inferior in various properties compared to the examples of the present invention.
【0030】[0030]
【発明の効果】以上記載のごとく、本発明が、皮膚の優
れた肌荒れ防止効果,角質改善効果,老化防止効果及び
美肌効果を発現し得る皮膚化粧料を提供することは明ら
かである。EFFECTS OF THE INVENTION As described above, it is clear that the present invention provides a skin cosmetic that can exhibit excellent skin roughness prevention effects, keratin improvement effects, anti-aging effects, and skin beautification effects.
Claims (2)
る成分と8−β−グルコピラノシル−7−ヒドロキシ−
3(3′,4′−ジヒドロキシフェニル)−4H−1−
ベンゾピラン−4−オンとを含有することを特徴とする
皮膚化粧料。Claim 1: A component having a blood circulation promoting effect or a cell activating effect and 8-β-glucopyranosyl-7-hydroxy-
3(3',4'-dihydroxyphenyl)-4H-1-
A skin cosmetic containing benzopyran-4-one.
る成分が、センブリエキス,朝鮮ニンジンエキス,ビタ
ミンE−オロテート,ジイソプロピルアミンジクロロア
セテート,γ−アミノ酪酸,D−パントテニルエチルエ
ーテル,D−パントテニルエチルアルコール,ビタミン
E−ニコチネート,ビオチンからなる群から選択された
少なくとも一種である請求項1に記載の皮膚化粧料。[Claim 2] The ingredients having a blood circulation promoting effect or a cell activating effect are Jasmine japonica extract, Korean ginseng extract, vitamin E-orotate, diisopropylamine dichloroacetate, γ-aminobutyric acid, D-pantothenyl ethyl ether, D-pantothenyl. The skin cosmetic according to claim 1, which is at least one selected from the group consisting of ethyl alcohol, vitamin E-nicotinate, and biotin.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3135452A JPH04334308A (en) | 1991-05-10 | 1991-05-10 | Skin cosmetic |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3135452A JPH04334308A (en) | 1991-05-10 | 1991-05-10 | Skin cosmetic |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH04334308A true JPH04334308A (en) | 1992-11-20 |
Family
ID=15152047
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP3135452A Pending JPH04334308A (en) | 1991-05-10 | 1991-05-10 | Skin cosmetic |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH04334308A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07215838A (en) * | 1994-02-04 | 1995-08-15 | Shiseido Co Ltd | Skin external agent |
| FR2717389A1 (en) * | 1994-03-18 | 1995-09-22 | Lvmh Rech | Use of ginsenoside Ro or a plant extract containing it to stimulate collagen synthesis. |
| WO1997036571A1 (en) * | 1996-04-01 | 1997-10-09 | Kao Corporation | Skin color improver |
| KR100513902B1 (en) * | 2001-12-24 | 2005-09-07 | 주식회사 코리아나화장품 | Cosmetic Compositions Comprising Extract from Panax ginseng(C.A.MEY) for Preventing Skin Aging |
-
1991
- 1991-05-10 JP JP3135452A patent/JPH04334308A/en active Pending
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07215838A (en) * | 1994-02-04 | 1995-08-15 | Shiseido Co Ltd | Skin external agent |
| FR2717389A1 (en) * | 1994-03-18 | 1995-09-22 | Lvmh Rech | Use of ginsenoside Ro or a plant extract containing it to stimulate collagen synthesis. |
| WO1995025524A1 (en) * | 1994-03-18 | 1995-09-28 | Lvmh Recherche | USE OF GINSENOSIDE Ro OR A PLANT EXTRACT CONTAINING SAME TO PROMOTE COLLAGEN SYNTHESIS |
| US5747538A (en) * | 1994-03-18 | 1998-05-05 | L.V.M.H. Recherche | Use of ginsenoside R0 or a plant extract containing same to promote collagen synthesis |
| WO1997036571A1 (en) * | 1996-04-01 | 1997-10-09 | Kao Corporation | Skin color improver |
| JPH09268118A (en) * | 1996-04-01 | 1997-10-14 | Kao Corp | Skin color improving beauty agent |
| CN1112913C (en) * | 1996-04-01 | 2003-07-02 | 花王株式会社 | Skin color improver |
| KR100513902B1 (en) * | 2001-12-24 | 2005-09-07 | 주식회사 코리아나화장품 | Cosmetic Compositions Comprising Extract from Panax ginseng(C.A.MEY) for Preventing Skin Aging |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3839618B2 (en) | Elastase inhibitor, and anti-aging skin external preparation comprising the same | |
| JP2002020225A (en) | Humectant composition | |
| JPH0873324A (en) | Hair nourishment | |
| US6193975B1 (en) | Use of potentilla erecta extract in the cosmetic and pharmaceutical field | |
| JPS6220165B2 (en) | ||
| DE69611082T2 (en) | BERTHOLLETIA CONTAINING COSMETIC OR PHARMACEUTICAL, IN PARTICULAR DERMATOLOGICAL COMPOSITION | |
| JP2003176213A (en) | Hair restorer | |
| JP3193542B2 (en) | Anti-aging skin cosmetics | |
| JPS6219511A (en) | Cosmetic for preventing aging of skin | |
| KR100767974B1 (en) | Cosmetic composition for pore reduction containing burdock extract and cold persimmon | |
| JPH1025236A (en) | Agent for improving and reinforcing nonuniformity of skin and cosmetic containing the same | |
| JPH0521085B2 (en) | ||
| JP3278138B2 (en) | External preparation for skin | |
| JP2009040694A (en) | Skin cosmetics | |
| JP3170700B2 (en) | Cosmetic for preventing skin aging | |
| JPS62138411A (en) | Cosmetic for preventing skin from ageing | |
| JP2006131558A (en) | Collagen formation promoter | |
| JP2002029923A (en) | Collagen production promoter, elastase activity inhibitor, collagen activity inhibitor and skin cosmetic | |
| JPS62148414A (en) | Skin cosmetic | |
| JP2001131031A (en) | Composition for scalp and hair | |
| JP2003342153A (en) | Skin care preparation, and dermal cell-activating composition, dermal fibroblast-activating composition, collagen production-promoting composition | |
| JP2001131047A (en) | Red bean extract-containing cosmetic composition | |
| JP2004175688A (en) | Whitening agents and cosmetics | |
| JP3503879B2 (en) | Cosmetics | |
| JPS62249907A (en) | Cosmetic |